Chiron slashes flu vaccine production forecast

Share this article:

Chiron Corp., one of only two major makers of the flu vaccine for the United States, cut its 2005 output forecast due to continuing problems with its Liverpool, England, factory.

The company plans to produce 18 million to 26 million doses of the Fluvirin vaccine for the upcoming season. It previously forecast making 25 million to 30 million doses.

Last year, Chiron failed to ship 50 million shots to the U.S., prompting a vaccine shortage and concerns about the most vulnerable receiving shots. The British government shut down the facility on Oct. 5 after Chiron discovered 4 million tainted flu shots.

GlaxoSmithKline could sell as many as 10 million flu shots in the U.S. this flu season, pending Food and Drug Administration approval of its marketing application. Sanofi is expected to supply 60 million shots and MedImmune Inc. of Gaithersburg, MD, is expected to provide 3 million doses of its nasal spray vaccine.

Share this article:

More in News

Rape investigation blocked by nursing home's HIPAA concerns, authorities say ...

Florida authorities say a nursing home is citing privacy laws to impede the investigation of a possible resident rape, according to local news reports.

Jury hands down $14 million negligent care verdict to 'send message' to nursing homes

Jury hands down $14 million negligent care verdict ...

A Massachusetts jury has awarded $14 million to the family of a nursing home resident who died due to a pressure ulcer, dehydration and other conditions linked to negligent care, ...

CCRC executive director salaries hold steady, therapy directors get boost

Continuing care retirement community executive director salaries have barely increased in the past year, while therapy and rehabilitation directors received a boost, a new report shows. The average salary for a therapy and rehab director is currently $95,905.